Pfizer
| Tip | javna kompanija |
|---|---|
| Simbol | NYSE: PFE Komponenta Dou Džonsa S&P 500 komponenta |
| Industrija | farmaceutska industrija |
| Osnovana | 1849 |
| Osnivač | Čarls Fajzer, Čarls Erhart |
| Sedište | Njujork Siti, Njujork; SAD |
| Područja | širom sveta |
| Ključni ljudi | Ijan Read (preds. & CEO) |
| Prihod | |
| Zarada | |
| Neto zarada | |
| Aktiva | |
| Akcijski kapital | |
| Zaposlenih | 110.600 (2010)[1] |
| Podružnice | Agouron farmaceutikals, G. D. Searl & kompanija |
| Vebsajt | Pfizer |
Fajzer (engl. Pfizer); (NYSE: PFE) američka je multinacionalna farmaceutska korporacija. Najpoznatiji su po tome što su izumeli vijagru.
Upravno sedište kompanije je Menhetn, Njujork,[2] dok je sedište za naučna istraživanja Grotonu, Konektikat, SAD. Pfizer proizvodi Lipitor (atorvastatin, koji se koristi za snižavanje krvnog holesterola); lek za neuropatski bol/fibromialgiju Lirika (pregabalin); oralni antifungalni lek Diflukan (flukonazol), antibiotik Zitromaks (azitromicin), Vijagra (sildenafil) za impotenciju, i antiinflamatorni Celebreks (celekoksib) (takođe poznat kao Celebra u nekim zemljama).
Pfizerove deonice su postale komponenta industrijskog indeksa Dau Džounsa 8. aprila, 2004.[3]
Pfizer je priznao krivicu 2009. za najveću zdravstvenu proneveru u istoriji SAD-a i kažnjen je najvećim kriminalnom kaznom ikad presuđenom za nelegalnu prodaju četiri svoja leka: Bekstra, Geodon, Zivoks, i Lirika. To je bila Pfizerova četvrta nagodba takve vrste sa Ministarstvom pravde Sjedinjenih Država u prethodnih deset godina.[4][5]
Reference
- ^ а б в г д ђ „2010 Form 10-K, Pfizer Inc.”. United States Securities and Exchange Commission.
- ^ "Contact Us." Pfizer. Retrieved on April 3, 2010.
- ^ Dow Jones Industrial Average Historical Components Архивирано на веб-сајту Wayback Machine (30. октобар 2011)
- ^ Harris, Gardiner (3. 9. 2009). „Pfizer Pays $2.3 billion to Settle Marketing Case”. The New York Times.
- ^ Johnson, Carrie (3. 9. 2009). „In Settlement, A Warning To Drugmakers: Pfizer to Pay Record Penalty In Improper-Marketing Case”. The Washington Post.
Literatura
- “Nigeria: Court Adjourns Killer Drug Case Against Pfizer”. All Africa Global Media. October 3, 2007.
- “Double Standards in Nigerian Health”. The American. June 26, 2007.
- “Nigeria Sues Pfizer Over Child Drug Trial”. West Africa Review. June 10, 2007.
- “Pfizer Faces $8.5 billion Suit Over Nigeria Drug Trial”. Reuters. September 30, 2007.
- “Pfizer Statement Concerning 1996 Nigerian Clinical Study” Архивирано на веб-сајту Wayback Machine (14. септембар 2010) Pfizer.
- “Pfizer Settlement Related to Off-Label Marketing” Архивирано на веб-сајту Wayback Machine (20. март 2012) K & M.
Spoljašnje veze
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.